Replies to post #502160 on NorthWest Biotherapeutics Inc (NWBO)

[sukus]

“They have the tools of HTF algos and a large pool of short shares to dictate the share price. “

Agree.

[CrashOverride]

An investment of $10 billion would be equivalent to $40 a share for common. That would allow the firm to initiate additional trials for DCVax-L so it can treat other cancer indications.

Given the patent cliff which many BPs are facing for their checkpoint inhibitors, I believe we will see more combination trials funded as well. Since there's an urgent need here to protect market share that's being threatened very soon I believe the partnership will be at this level of scale. BP partners know spending money must happen to create long term revenue so I believe the partnership will be:

"Go Big Or Go Home!"

Being first to capture market share matters as that helps establish a durable competitive advantage. So BP partner will not dither around with a few hundred million as that's not enough for them to ensure we make it impossible for competitors to arise in the same market. A single trial costs half a billion. Thus the JV will be billions and billions. This would be my strategy if I was in a position to partner with Northwest Biotherapeutics.

[iwasadiver]

I couldn’t agree with you more. You know the trading arena better than I do but I can see with my own eyes how things work here. I believe the stage is set and the pieces are just about all to fall into place

[eagle8]

Great post jimmy667.
100% agreed.
Thanks and GLTU.

[StockFollower]

Excellent Post Jimmy667 - the board should sticky this.

SF

[Poor Man -]

There seems to be a carve out for penny stocks under the Penny Stock Provisions in the Nasdaq Listing Requirements to get around the 90 day min bid requirement.

This might allow the company’s stock to be treated as an Initial Listing as if listing for the first time as a private company. The preferred would have to be priced equivalent to $4 per common share.

Have to take a closer look later at the penny stock exception, but that would be huge to allow for a quick listing and not require a reverse split.

5510. Initial Listing Requirements for Preferred Stock and Secondary Classes of Common Stock

(a) When the Primary Equity Security is listed on the Capital Market or is a Covered Security, a Company's preferred stock or secondary class of common stock must meet all of the requirements in Rules (1) through (6) below in order to be listed.

(1) Minimum bid price of at least $4 per share;

(2) At least 100 Round Lot Holders and at least 50% of such Round Lot Holders must each hold Unrestricted Securities with a Market Value of at least $2,500;

(3) At least 200,000 Unrestricted Publicly Held Shares;

(4) Market Value of Unrestricted Publicly Held Shares of at least $3.5 million;

(5) At least three registered and active Market Makers; and


(6) If the security is trading in the U.S. over-the-counter as of the date of application, such security must have a minimum average daily trading volume of 2,000 shares over the 30 trading day period prior to listing, with trading occurring on more than half of those 30 days, unless such security is listed on the Exchange in connection with a firm commitment underwritten public offering of at least $4 million.

(b) In the event the Company's Primary Equity Security is not listed on the Capital Market or is not a Covered Security, the preferred stock and/or secondary class of common stock may be listed on the Capital Market so long as it satisfies the initial listing criteria for Primary Equity Securities set forth in Rule 5505.

Adopted March 12, 2009 (SR-NASDAQ-2009-018); amended July 5, 2019 (SR-NASDAQ-2019-009), operative Aug. 4, 2019.